机构:[1]Department of Traditional Chinese Medicine,Beijing Tongren Hospital,Capital Medical University,Beijing 100730,China首都医科大学附属北京同仁医院首都医科大学附属同仁医院临床科室传统医学科[2]Jococo Inc, Los Angeles, CA, USA[3]President of the International Society for Medical Laser Applications (ISLA transcontinental since 2012), German Vice President of the German-Chinese Research Foundation (DCFG) for TCM (since 2014), Vice Chairperson, World Federation of Chinese Medicine Societies, Committee of Card. Rehab. (2023-2028), Honorary President of the European Federation of Acupuncture and Moxibustion Societies (2023), Honorary Professor of China Beijing International Acupuncture Training Center, China Academy of Chinese Medical Sciences (2023), Former Head of two Research Units at Medical University of Graz, 8036 Graz, Austria[4]Department of Otolaryngology Head and Neck Surgery,Beijing Tongren Hospital,Capital Medical University,Beijing,China首都医科大学附属北京同仁医院首都医科大学附属同仁医院临床科室耳鼻咽喉-头颈外科[5]Department of Neurology,Beijing Tongren Hospital,Capital Medical University,Beijing,China首都医科大学附属北京同仁医院首都医科大学附属同仁医院临床科室神经内科[6]TED Healthcare Technology Ltd (Beijing), Beijing, China [7]Beijing Institute of Ophthalmology,Beijing Tongren Hospital,Capital Medical University,Beijing,China首都医科大学附属北京同仁医院首都医科大学附属同仁医院研究所眼科研究所[8]Institute of Acupuncture-Moxibustion, China Academy of Chinese Medical Sciences, Beijing, China
To investigate the efficacy of laser acupuncture and photobiomodulation therapy in alleviating symptoms among patients diagnosed with Bell's palsy with duration of greater than 8 weeks. The randomized controlled trial has been performed from May 2021 to April 2023. Patients were eligible who had Bell's palsy with duration of greater than 8 weeks on out-patient Department of Otorhinolaryngology in Beijing Tongren Hospital. The laser acupuncture group received class IV laser treatment for 3 times per weeks, a total of 72 times. The control group received the same treatment procedure except the laser parameter. The primary outcome measures comprised House-Brackmann facial nerve grading system and electroneurography. Secondary outcome measures comprised Sunnybrook facial grading system, electromyography, and the blink reflex. A total of 84 participants were included (42 control group, 42 laser acupuncture group). After treatment, House-Brackmann facial nerve grading system (OR, 0.11; 95% CI, 0.04-0.30; P < 0.001), and the pathologic numbers of electroneuronography were statistically different between the laser acupuncture group and control group, including orbicularis oculi (OR,0.08; 95% CI, 0.02-0.21; P < 0.001), Frontalis muscle (OR,0.14; 95% CI, 0.05-0.39; P < 0.001), Orbicularis oris (OR,0.13; 95% CI, 0.04-0.36; P < 0.001), Ala nasi muscle (OR,0.06; 95% CI, 0.02-0.18; P < 0.001). In secondary outcomes, Sunnybrook facial grading system, has significant difference between the two groups (20.26; 95% CI, 14.69 to 25.83; P < 0.01). Latency by ENoG, include orbicularis oculi (-0.61; 95% CI, -0.43 to -0.09; P < 0.001), frontalis muscle (-0.12; 95% CI, -0.21 to -0.03; P < 0.01), orbicularis oris (-0.28; 95% CI, -0.41 to -0.16; P < 0.001), and ala nasi muscle (-0.26; 95% CI, -0.38 to -0.16; P < 0.001). All amplitudes of MUAPs and durations by electromyography (EMG) showed statistically significant differences compared with the control group after treatment. For the frontalis muscle, the amplitude of MUAPs was -64.23 (95% CI, -80.89 to -47.56; P < 0.001) and duration was -1.18 (95% CI, -1.49 to -0.87; P < 0.001). For orbicularis oris, amplitude of MUAPs was -29.82 (95% CI, -55.03 to -4.62; P = 0.02) and duration was -0.57 (95% CI, -0.94 to -0.20; P < 0.001). For depressor angulli oris, amplitude of MUAPs was -47.06 (95% CI, -62.15 to -31.97; P < 0.001) and duration was -2.21 (95% CI, -2.69 to -1.72; P < 0.001). Blink reflex, including R1 (OR, 0.03; 95% CI, 0.01-0.16; P < .001), R2 (OR, 0.04; 95% CI, 0.004-0.29; P < .001), and R2 latency differences (OR, 0.15; 95% CI, 0.05-0.51; P < .001), have significant difference between the two groups, respectively. The findings suggest that laser acupuncture relieve symptoms for patients with Bell's palsy with a duration of greater than 8 weeks.
基金:
1. National Key R&D Prog ram of China No.2022YFC2504100.
2. Beijing Natural Science Foundation, No. 7212166.
3.High-level Public Health Talents Training Program of Beijing Municipal Health Commission, No.02–046.
第一作者机构:[1]Department of Traditional Chinese Medicine,Beijing Tongren Hospital,Capital Medical University,Beijing 100730,China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Dong Wu,Xin Lan,Gerhard Litscher,et al.Laser acupuncture and photobiomodulation therapy in Bell's palsy with a duration of greater than 8 weeks: a randomized controlled trial[J].LASERS IN MEDICAL SCIENCE.2024,39(1):doi:10.1007/s10103-023-03970-4.
APA:
Dong Wu,Xin Lan,Gerhard Litscher,Yan‑Ling Zhao,Yun‑Qing Wu...&Lu‑Quan Chen.(2024).Laser acupuncture and photobiomodulation therapy in Bell's palsy with a duration of greater than 8 weeks: a randomized controlled trial.LASERS IN MEDICAL SCIENCE,39,(1)
MLA:
Dong Wu,et al."Laser acupuncture and photobiomodulation therapy in Bell's palsy with a duration of greater than 8 weeks: a randomized controlled trial".LASERS IN MEDICAL SCIENCE 39..1(2024)